Pfizer and the Hemostasis & Thrombosis Research Society (HTRS) are offering an Independent Medical Education grant opportunity supporting Visiting Professorships for organizations with identified needs for hemophilia-focused education.

Overview

This Visiting Professorship Program supports the coordination of a medical education program led by a distinguished Visiting Professor. The expertise of the Visiting Professor is matched to specific unmet educational needs surrounding shared decision making (SDM) and emerging therapeutic options in hemophilia. The program is designed to benefit clinicians, physician-scientists, multidisciplinary care teams, and patient advocacy group members at the recipient organization.

The Hemostasis and Thrombosis Research Society, Inc. (HTRS) is the leading North American professional society dedicated to research, mentoring, workforce development, and continuing medical education for physicians, investigators, and all health care professionals interested in advancing care for people with hemostatic and thrombotic disorders. Pfizer supports the global healthcare community’s independent education initiatives to improve patient outcomes in areas of unmet medical need that are aligned with medical and/or scientific strategies.

Eligibility

The opportunity is geographically limited to the United States.

Eligible applicants include professional medical, nursing, allied health, dental, or pharmacy schools; universities and academic healthcare institutions (both large and small); patient advocacy groups, nonprofit professional organizations, or medical societies.

Important Eligibility Notes:

• Only organizations are eligible to receive grants. Individuals or independent groups of physicians not affiliated with a hospital, academic institution, or professional society are not eligible.
• If the project involves multiple departments or different institutions, every involved organization must play a defined and relevant role.
• The applicant organization must designate an individual to serve as the Project or Program Lead, who must be an employee or contractor of the requesting organization.
• Proof of accreditation is required if the project offers continuing education credit.

Program Focus and Requirements

The primary area of interest for this Request for Proposals (RFP) is Hemophilia. The intent is to invite healthcare institutions and/or patient advocacy groups with identified needs for hemophilia-focused education to apply to host a medical education program lasting up to two days. The program will be led by one or two Visiting Professor(s), identified by HTRS, whose expertise aligns with the organization’s unmet educational needs regarding SDM and emerging therapeutic options in hemophilia care.

Applicants must submit an online application form that includes:

• A description of the Organization’s medical gaps, unmet needs, challenges, and questions surrounding SDM and emerging therapeutic options for hemophilia care.
• The proposed agenda for a Visiting Professorship Program up to two-days in length.
• Expected or desired outcomes, including an outline of 6-month outcome metrics detailing enduring changes or improvements in patient care and physician education/knowledge.
• A Proposed Budget of Logistics Expenses.
• Proof of Accreditation, if applicable.

The target audience for the program includes academic clinicians, physician-scientists, multidisciplinary care teams (MDTs), and patient advocacy groups.

Funding and Benefits

Individual grant amounts are available up to $6,000 USD to cover local costs, such as meeting room rental, AV support, local onsite management, onsite logistics, or planning and staffing needs. Travel expenses and honoraria for the Visiting Professor are covered separately and must not be included in the grant application budget.

Application Process and Timeline

Applications must be submitted through the designated online portal at www.cybergrants.com/pfizer/knowledge. Applicants must click “Start A New Knowledge Gap Application” and ensure all required sections are completed.

Key Dates:

• RFP release date: April 23, 2026
• Application Deadline: On or before 5:00 PM ET on June 18, 2026.
• Decision Notification: All applicants will be notified via email on or before July 30, 2026.
• Program Start Date must be after: June 18, 2026, and on or before November 1, 2026.

The required components for a complete proposal include the Completed Application Form, Project Plan/Proposal or Meeting Agenda, a Letter of Support from the Organization, the Proposed Budget of Logistic Expenses, and Proof of Accreditation (if applicable).

If the grant is approved, the institution will be required to enter into a written grant agreement with Pfizer.